Seikagaku engages in initiatives to address social and environmental problems in pursuit of harmony and continuous growth together with local communities. And we pursues respect for learning by engaging in global research assistance and sponsoring activities that support the development of glycoscience.
Ibaraki-no-Kusuriten (Ibaraki Medicine Exhibition) disseminates correct knowledge of medicine
Seikagaku exhibited at Ibaraki-no-Kusuriten in October 2019, a medicine exhibition hosted by Ibaraki Prefecture each year to coincide with Medicine and Health Week. The purpose of Ibaraki-no-Kusuriten (Ibaraki Medicine Exhibition) is to inform the general public of the importance of correctly using medicines through an exhibition that introduces pharmaceuticals, medical devices, quasi-drugs, and other products produced at plants in Ibaraki Prefecture and events, such as a quiz rally to deepen understanding of medicine and a participatory simulation of prescription filling.
Since Seikagaku has a pharmaceutical manufacturing plant in Takahagi City, Ibaraki Prefecture, we have a display area at the exhibition each year where Takahagi Plant and Business Development & Marketing Division employees introduce visitors to Seikagaku’s business activities and the characteristics of hyaluronic acid and promote awareness of diseases addressed by Seikagaku products with the aim of promoting understanding of the role Seikagaku products play in everyday life. The exhibition serves as an opportunity for employees to experience a sense of responsibility for our products while at the same time spreading proper understanding of pharmaceuticals.
Horseshoe crab conservation activities of Associates of Cape Cod, Inc.
Since Seikagaku’s U.S. subsidiary Associates of Cape Cod, Inc. (ACC) manufactures and sells reagents* using a substance extracted from horseshoe crab blood cells as a raw material, it continuously engages in horseshoe crab conservation activities to protect this precious natural resource. In addition to supporting the American horseshoe crab, in 2019, ACC began providing assistance for activities to maintain the population of Asian horseshoe crabs in the form of customized aquaculture equipment and training. Maintaining the population involves growing survivable juveniles produced by in vitro fertilization of sperm and eggs and releasing them into the natural environment. ACC has long engaged in this activity and accumulated related technology and expertise.
This assistance will be made available to academic institutions and private sector researchers around the world, and already had started with organizations in China and Malaysia. Organizations receiving assistance will be granted a license to use ACC proprietary technology and expertise free of charge, and they are provided customized tools, instruction in in vitro fertilization methods and training in the operation of highly efficient aquaculture equipment.
The number of American horseshoe crabs that ACC has released in the Commonwealth of Massachusetts exceeded 800,000 in 2020. The Seikagaku Group will continue to promote activities to conserve and sustain horseshoe crab populations worldwide, and strive to use this precious resource in a sustainable, responsible manner.
* Endotoxin-detecting reagents used in quality control for manufacturing processes of pharmaceuticals and medical devices
Glycoforum, a website for comprehensive information on glycoscience research
Since 1997, Seikagaku has operated “Glycoforum,” an academic website that shares information about research findings to contribute to the development of glycoscience, which is one of Seikagaku’s areas of specialization.
As a portal site for glycoscience information, the website promptly disseminates science paper information, including commentary from global leading researchers and academic conference information. The site enjoys strong support from researchers in Japan and overseas.
Support for the Mizutani Foundation for Glycoscience
The Mizutani Foundation for Glycoscience was established in 1992 with an endowment from the late Masakane Mizutani, former president of Seikagaku Corporation, for the purpose of contributing to the welfare of humanity through the advancement and development of glycoscience. The Foundation provides research grants to glycoscience researchers in Japan and overseas and supports conferences. In fiscal 2019, the Foundation provided research grants totaling approximately ¥66.8 million to 16 grant recipients.
Seikagaku endorses the purpose of the Foundation and has continuously supported its activities since its founding.
Promoting early treatment of knee osteoarthritis Hiza Ikiiki (Sprightly Knees), a website for provision of information concerning knee osteoarthritis to the general public
Some 30 million patients* in Japan are said to suffer from knee osteoarthritis, a disorder marked by knee joint strain due to aging, excessive exercise, or weight increase causing the cartilage to gradually wear away. The Hiza Ikiiki website explains basic knowledge concerning knee osteoarthritis, diagnosis, and treatment methods in an easy to understand way and gives information on nearby medical institutions that operate outpatient clinics and provide treatment for knee pain. Visitors can also download a pamphlet “Exercise therapy of knee osteoarthritis.”
We will provide correct knowledge to people with knee pain and further enhance website content to enable greater numbers to promptly obtain appropriate treatment.
* “Locomotive Disorder Countermeasures to Promote Preventive Care,”
a report from the Ministry of Health, Labour, and Welfare” issued in 2008